TNBC: triple-negative breast cancer, HER2+ve: human epidermal growth factor receptor 2 positive, HER2-ve: human epidermal growth factor receptor 2 negative, IDC: invasive ductal carcinoma. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.